Articles From: Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results to Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update


- Revenues up 38% from prior year period - New line of credit established with SunTrust Bank NASHVILLE, Tenn.
Sign-up for Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results investment picks
Recent Business Highlights Second Quarter 2014 Highlights Total prescriptions for Zohydro ER were 10,299 for the second quarter; 4,076 for the first four weeks of July, up 74% compared to the first four weeks of April; and 1,088 for the most recent week ended July 25 1 Total net revenue of $9.2 million Zohydro ER net revenue of $2.4 million on prescription demand Zohydro ER gross factory sales to wholesalers of $4.8 million during the second quarter; $11.6 million year-to-date SAN DIEGO, Aug.
Sign-up for Zogenix Reports Second Quarter 2014 Financial Results investment picks
WPX Energy’s (NYSE:WPX) unaudited results for the second quarter of 2014 reflect a 57 percent jump in domestic oil production and stronger than expected natural gas production vs.
Sign-up for WPX Energy 2Q Results Show Surge in Oil Production, Outlook investment picks
Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil and building construction company, today reported results for the second quarter of 2014.
Sign-up for Tutor Perini Reports Second-Quarter Results investment picks
Pulse Electronics Corporation (NYSE:PULS), a leading provider of electronic components, today reported results for its second quarter ended June 27, 2014.
Sign-up for Pulse Electronics Corporation Reports Second Quarter Results investment picks
CEDAR RAPIDS, Iowa , Aug.
Sign-up for Interstate Power and Light Company declares preferred stock dividend investment picks
MOUNTAIN VIEW, Calif., Aug.
Sign-up for ChemoCentryx Announces Financial Results for the Second Quarter Ended June 30, 2014 investment picks
Second Quarter 2014 Revenue $642.2Million, Up 11 Percent; GAAP Operating Margin 15.1 Percent; Non-GAAP Operating Margin 23.2 Percent; GAAP Diluted Earnings Per Share $0.29; Non-GAAP Diluted Earnings Per Share $0.45 SUNNYVALE, Calif.
Sign-up for Trimble Reports Second Quarter 2014 Results investment picks
EMERYVILLE, Calif., Aug.
Sign-up for United States Patent Issued to Adamas Pharmaceuticals investment picks
PENNSAUKEN, N.J., Aug.
Sign-up for RCM Technologies, Inc. Announces Conference Call investment picks
Ladder Capital Corp (NYSE:LADR) (“we,” “Ladder,” or the “Company”) today announced operating results for the quarter ended June 30, 2014.
Sign-up for Ladder Capital Corp Reports Second Quarter 2014 Results investment picks
Paycom Software, Inc. (“Paycom”) (NYSE:PAYC), a leading provider of a comprehensive cloud-based human capital management software solution, today announced its financial results for the quarter ended June 30, 2014.
Sign-up for Paycom Software Reports 39.3% Revenue Growth in the Second Quarter 2014 investment picks
Colony Financial, Inc. (NYSE: CLNY) (the “Company”) today announced financial results for the second quarter ended June 30, 2014 and declares a dividend of $0.36 per share of common stock for the third quarter of 2014.
Sign-up for Colony Financial Announces Second Quarter 2014 Financial Results investment picks
MIDLAND, Texas, Aug.
Sign-up for Diamondback Energy, Inc. Announces Second Quarter 2014 Financial and Operating Results investment picks
LAS VEGAS, Aug.
Sign-up for Global Cash Access Reports Second Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201204/39376_FireEye_logo_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135560&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for FireEye Reports Financial Results for Second Quarter 2014 investment picks
http://media.marketwire.com/attachments/200910/575184_PegaLogoBlue2.jpg.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135547&ProfileId=051205&sourceType=1 CAMBRIDGE, MA --
Sign-up for Pegasystems Announces Financial Results for Second Quarter and First Six Months of 2014 investment picks
BOTHELL, Wash., Aug.
Sign-up for Alder BioPharmaceuticals Reports Second Quarter 2014 Financial and Operating Results investment picks
http://media.marketwire.com/attachments/201204/39376_FireEye_logo_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135636&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for FireEye Announces John McGee as SVP, Worldwide Sales investment picks
http://media.marketwire.com/attachments/200506/213915_DryShips.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135523&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for DryShips Inc. Reports Financial and Operating Results for the Second Quarter 2014 investment picks
GAMCO Investors, Inc. (NYSE:GBL) announced today that its Board of Directors approved a quarterly dividend of $0.06 per share to all of its Class A and Class B shareholders, payable on September 30, 2014 to its Class A and Class B shareholders of record on September 16, 2014.
Sign-up for GAMCO Board Approves Quarterly Dividend of $0.06 Per Share investment picks
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and developer of molecular diagnostic products, today announced that it has received market approval from the Australian Therapeutic Goods Administration (TGA), clearing the company to market its Prosigna ™ Breast Cancer Prognostic Gene Signature Assay for assessing a woman’s risk of distant recurrence of disease.
Sign-up for NanoString Technologies Receives Market Approval From the Australian Therapeutic Goods Administration for Its Prosigna Breast Cancer Prognostic Gene Signature Assay investment picks
http://media.marketwire.com/attachments/201203/26852_oceanrig.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135524&ProfileId=051205&sourceType=1 NICOSIA, CYPRUS --
Sign-up for Ocean Rig UDW Inc. Reports Financial and Operating Results for the Second Quarter 2014 investment picks
NEW YORK, Aug.
Sign-up for New York Mortgage Trust Reports Second Quarter 2014 Results investment picks
- Strong Q2 2014 Revenue Growth of 51% Year over Year - - Initiation of First Companion Diagnostic Collaboration with Celgene Corporation - SEATTLE, Aug.
Sign-up for NanoString Technologies Releases Financial Results for Second Quarter of 2014 investment picks
Jazz Pharmaceuticals owns worldwide rights to defibrotide DUBLIN , Aug.
Sign-up for Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. investment picks
ALISO VIEJO, Calif.
Sign-up for Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results to Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices